Whole-exome sequencing reveals candidate high-risk susceptibility genes for endometriosis

Autor: Susanna Nousiainen, Outi Kuismin, Siiri Reinikka, Roosa Manninen, Sara Khamaiseh, Mari Kuivalainen, Anna Terho, Sari Koivurova, Maarit Niinimäki, Kari Salokas, Markku Varjosalo, Anne Ahtikoski, Ralf Bützow, Outi Lindgren, Outi Uimari, Pia Vahteristo

Publikováno v: Human Genomics, Vol 17, Iss 1, Pp 1-10 (2023)

Abstract Background Endometriosis is a common, chronic disease among fertile-aged women. Disease course may be highly invasive, requiring extensive surgery. The etiology of endometriosis remains elusive, though a high level of heritability is well es

Externí odkaz: https://doaj.org/article/6dacf57f4e0f49a8840d6d3a6215fa94

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PROSHADE – Tietoon pohjautuva jaettu päätöksenteko terveydenhuollossa

Autor: Milla Rosenlund, Virpi Jylhä, Anna Vahteristo, Tuuli Turja, Hanna Kuusisto

Publikováno v: Finnish Journal of eHealth and eWelfare, Vol 15, Iss 2 (2023)

PROSHADE on Suomen Akatemian Strategisen tutkimuksen neuvoston (STN) vuosille 2021–2026 rahoittama hanke ja osa STN:n LITERACY-ohjelmaa. Hankkeessa tutkitaan ja etsitään monitieteellisesti ratkaisuja tiedon kriittiselle käytölle yhteiskunnassa.

Externí odkaz: https://doaj.org/article/211101cd816545f29ba9b5f009268483

Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD

Autor: Jõgi R, Mattila L, Vahteristo M, Takala A, Lähelmä S, Vartiainen VA, Lindqvist A

Publikováno v: International Journal of COPD, Vol Volume 16, Pp 1193-1201 (2021)

Rain Jõgi,1 Leena Mattila,2 Mikko Vahteristo,3 Aino Takala,2 Satu Lähelmä,4 Ville A Vartiainen,2 Ari Lindqvist5 1Tartu University Hospital, Lung Clinic, Tartu, Estonia; 2Medical Affairs, Orion Corporation, Espoo, Finland; 3Research Unit of Pulmona

Externí odkaz: https://doaj.org/article/62f85c9918884c30ab4f800f85865080

Clinical and molecular risk factors for repeat interventions due to symptomatic uterine leiomyomas.

Autor: Khamaiseh S; Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland., Äyräväinen A; Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland; Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Arffman M; Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland., Reinikka S; Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland., Mehine M; Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland., Härkki P; Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Bützow R; Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland; Department of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland., Pasanen A; Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland., Vahteristo P; Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland. Electronic address: pia.vahteristo@helsinki.fi.

Publikováno v: American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2024 Jul 31. Date of Electronic Publication: 2024 Jul 31.